1. Home
  2. UK vs OGEN Comparison

UK vs OGEN Comparison

Compare UK & OGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UK
  • OGEN
  • Stock Information
  • Founded
  • UK 2015
  • OGEN 1996
  • Country
  • UK China
  • OGEN United States
  • Employees
  • UK N/A
  • OGEN N/A
  • Industry
  • UK Business Services
  • OGEN Biotechnology: Pharmaceutical Preparations
  • Sector
  • UK Consumer Discretionary
  • OGEN Health Care
  • Exchange
  • UK Nasdaq
  • OGEN Nasdaq
  • Market Cap
  • UK 2.2M
  • OGEN 2.5M
  • IPO Year
  • UK N/A
  • OGEN N/A
  • Fundamental
  • Price
  • UK $1.02
  • OGEN $1.40
  • Analyst Decision
  • UK
  • OGEN
  • Analyst Count
  • UK 0
  • OGEN 0
  • Target Price
  • UK N/A
  • OGEN N/A
  • AVG Volume (30 Days)
  • UK 14.5K
  • OGEN 1.3M
  • Earning Date
  • UK 07-29-2025
  • OGEN 08-08-2025
  • Dividend Yield
  • UK N/A
  • OGEN N/A
  • EPS Growth
  • UK N/A
  • OGEN N/A
  • EPS
  • UK N/A
  • OGEN N/A
  • Revenue
  • UK $23,924,045.00
  • OGEN N/A
  • Revenue This Year
  • UK N/A
  • OGEN N/A
  • Revenue Next Year
  • UK N/A
  • OGEN N/A
  • P/E Ratio
  • UK N/A
  • OGEN N/A
  • Revenue Growth
  • UK N/A
  • OGEN N/A
  • 52 Week Low
  • UK $0.98
  • OGEN $1.30
  • 52 Week High
  • UK $2.26
  • OGEN $75.60
  • Technical
  • Relative Strength Index (RSI)
  • UK 47.10
  • OGEN 28.42
  • Support Level
  • UK $1.02
  • OGEN $1.30
  • Resistance Level
  • UK $1.11
  • OGEN $1.58
  • Average True Range (ATR)
  • UK 0.04
  • OGEN 0.15
  • MACD
  • UK 0.00
  • OGEN 0.02
  • Stochastic Oscillator
  • UK 30.77
  • OGEN 4.07

About UK Ucommune International Ltd

Ucommune International Ltd is a flexible office space provider and manager based in the People's Republic of China (PRC). The company offers long-term leasing, on-demand, and short-term leasing solutions to freelancers, start-up entrepreneurs, small and medium enterprises, and corporations. Company provide fully-serviced and well-furnished office spaces on a flexible basis. The members of the Ucommune community, which includes individuals and enterprises registered on the U bazaar mobile app, can avail of these services. The company has three operating segments: Workspace membership, Marketing and branding services, and Other services. Marketing and branding services generate the majority of the company's revenue.

About OGEN Oragenics Inc.

Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification. The Company operates in one reportable segment, which includes activities related to advancing the development of its concussion drug, ONP-002.

Share on Social Networks: